These seven markers were: Pentraxin-3 (‘disturbed vasculogenesis’), VCAM-1 and ICAM-1 (both EC Activation), Thrombomodulin (‘coagulopathy’), MCP-1, IP-10 and VEGF (all ‘disturbed angiogenesis’). This evidence concerns the gene ICAM1 and blood coagulation disease.